<SEC-DOCUMENT>0000920465-14-000084-index.html : 20140725
<SEC-HEADER>0000920465-14-000084.hdr.sgml : 20140725
<ACCEPTANCE-DATETIME>20140725161954
ACCESSION NUMBER:		0000920465-14-000084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20140722
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140725
DATE AS OF CHANGE:		20140725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		14994516

	BUSINESS ADDRESS:	
		STREET 1:		4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kjuly25th2014.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a8-kjuly25th2014.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>underwritingagreement.htm
<DESCRIPTION>EXHIBIT
<TEXT>
Document 2 - file: underwritingagreement.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit518-k2014july.htm
<DESCRIPTION>EXHIBIT
<TEXT>
Document 3 - file: exhibit518-k2014july.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gdlogo.jpg
<TEXT>
Document 4 - file: gdlogo.jpg

</DOCUMENT>
</SEC-DOCUMENT>